This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
According to recent research published in the journal Cancer Epidemiology Biomarkers & Prevention, Colorectal cancer incidence was reduced among women assigned to active treatment in the Women's Health Initiative (WHO estrogen plus progestin-randomized trial, but the interpretation was obscured by an associated later stage of diagnosis. in contrast, the estrogen-alone trial showed no incidence reduction or differential stage at diagnosis.
We care about your feedback. Let us know how we can improve your CancerCompass experience.